⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NTRA News
Natera, Inc. Common Stock
RARE Drug Development Symposium Marks 10th Anniversary with Dedicated Pitch Sessions and The Theme and Call to Action to Align Advocates, Science and Industry
prnewswire.com
BIIB
REGN
GILD
BTE
BROS
BFLY
BCTX
BCRX
BTAI
ALRS
CAPR
CRIS
CYCN
EXAS
FATE
GNTX
HRMY
INCY
IONS
KODK
LAKE
LULU
MRNA
NBIX
NTRA
OCGN
ORGN
PGEN
PLRX
RARE
RGNX
RXRX
SAVA
SGMO
SNOW
SRPT
STEM
TGTX
TLSA
TXG
VRTX
ZETA
Signatera™ MRD Outperformed AMERK Testing in Predicting Merkel Cell Carcinoma Recurrence in JAMA Dermatology Study
businesswire.com
NTRA
Finalized MolDx LCD Includes Expanded Coverage for Natera’s Prospera™ Portfolio
businesswire.com
NTRA
Global Non-Invasive Prenatal Testing Market Report — Just Released; Comprehensive 181-Page Analysis with Broad Product and Application Scope
globenewswire.com
RVTY
ILMN
NTRA
QGEN
Natera Announces IVDR Certification for Signatera™ Across Multiple Cancers
businesswire.com
NTRA
Form 8-K
sec.gov
NTRA
Signatera™ MRD Test Predicted Overall Survival Benefit from Chemotherapy in Resected Metastatic Colorectal Cancer
businesswire.com
NTRA
Oncology Precision Medicine Market Trends & Opportunities Forecast 2021-2031
globenewswire.com
AMRX
NTRA
Minimal Residual Disease Testing Market Size to Reach USD 7.97 Billion by 2035 at 11.50% CAGR | Industry Report by SNS Insider
globenewswire.com
ABT
NTRA
GRDX
LH
Natera and Aveta Biomics Announce Strategic Partnership Supporting Global Phase 3 Registrational Trial of APG-157 in Head and Neck Cancer
businesswire.com
NTRA